Gallagher Brian M. Jr. - Net Worth and Insider Trading
Gallagher Brian M. Jr. Net Worth
The estimated net worth of Gallagher Brian M. Jr. is at least $138 Million dollars as of 2024-11-10. Gallagher Brian M. Jr. is the Director of Translate Bio Inc and owns about 3,697,912 shares of Translate Bio Inc (TBIO) stock worth over $138 Million. Gallagher Brian M. Jr. is the Director of Aileron Therapeutics Inc and owns about 71,576 shares of Aileron Therapeutics Inc (ALRN) stock worth over $269,842. Gallagher Brian M. Jr. is also the Director of eFFECTOR Therapeutics Inc and owns about 1,200 shares of eFFECTOR Therapeutics Inc (EFTR) stock worth over $0. Details can be seen in Gallagher Brian M. Jr.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gallagher Brian M. Jr. has not made any transactions after 2022-06-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gallagher Brian M. Jr.
Gallagher Brian M. Jr. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gallagher Brian M. Jr. owns 3 companies in total, including Translate Bio Inc (TBIO) , Aileron Therapeutics Inc (ALRN) , and eFFECTOR Therapeutics Inc (EFTR) .
Click here to see the complete history of Gallagher Brian M. Jr.’s form 4 insider trades.
Insider Ownership Summary of Gallagher Brian M. Jr.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TBIO | Translate Bio Inc | 2018-07-02 | director |
| ALRN | Aileron Therapeutics Inc | 2017-07-05 | director |
| EFTR | eFFECTOR Therapeutics Inc | 2022-06-23 | director & 10 percent owner |
Gallagher Brian M. Jr. Latest Holdings Summary
Gallagher Brian M. Jr. currently owns a total of 3 stocks. Among these stocks, Gallagher Brian M. Jr. owns 3,697,912 shares of Translate Bio Inc (TBIO) as of July 2, 2018, with a value of $138 Million and a weighting of 99.81%. Gallagher Brian M. Jr. owns 71,576 shares of Aileron Therapeutics Inc (ALRN) as of July 5, 2017, with a value of $269,842 and a weighting of 0.19%. Gallagher Brian M. Jr. also owns 1,200 shares of eFFECTOR Therapeutics Inc (EFTR) as of June 23, 2022, with a value of $0 and a weighting of 0%.
Latest Holdings of Gallagher Brian M. Jr.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TBIO | Translate Bio Inc | 2018-07-02 | 3,697,912 | 37.36 | 138,153,992 |
| ALRN | Aileron Therapeutics Inc | 2017-07-05 | 71,576 | 3.77 | 269,842 |
| EFTR | eFFECTOR Therapeutics Inc | 2022-06-23 | 1,200 | 0.00 | 0 |
Holding Weightings of Gallagher Brian M. Jr.
Gallagher Brian M. Jr. Form 4 Trading Tracker
According to the SEC Form 4 filings, Gallagher Brian M. Jr. has made a total of 0 transactions in Translate Bio Inc (TBIO) over the past 5 years. The most-recent trade in Translate Bio Inc is the acquisition of 269,230 shares on July 2, 2018, which cost Gallagher Brian M. Jr. around $3 Million.
According to the SEC Form 4 filings, Gallagher Brian M. Jr. has made a total of 0 transactions in Aileron Therapeutics Inc (ALRN) over the past 5 years. The most-recent trade in Aileron Therapeutics Inc is the acquisition of 13,667 shares on July 5, 2017, which cost Gallagher Brian M. Jr. around $4 Million.
According to the SEC Form 4 filings, Gallagher Brian M. Jr. has made a total of 1 transactions in eFFECTOR Therapeutics Inc (EFTR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in eFFECTOR Therapeutics Inc is the acquisition of 1,200 shares on June 23, 2022, which cost Gallagher Brian M. Jr. around $47,700.
Insider Trading History of Gallagher Brian M. Jr.
- 1
Gallagher Brian M. Jr. Trading Performance
GuruFocus tracks the stock performance after each of Gallagher Brian M. Jr.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gallagher Brian M. Jr. is -22.57%. GuruFocus also compares Gallagher Brian M. Jr.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Gallagher Brian M. Jr. within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gallagher Brian M. Jr.'s insider trading performs compared to the benchmark.
Performance of Gallagher Brian M. Jr.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -19.11 | | | | | |
| Relative Return to S&P 500(%) | -22.4 | | | | | |
Gallagher Brian M. Jr. Ownership Network
Ownership Network List of Gallagher Brian M. Jr.
Ownership Network Relation of Gallagher Brian M. Jr.
Gallagher Brian M. Jr. Owned Company Details
What does Translate Bio Inc do?
Who are the key executives at Translate Bio Inc?
Gallagher Brian M. Jr. is the director of Translate Bio Inc. Other key executives at Translate Bio Inc include director & Chief Executive Officer & other: President Renaud Ronald C Jr , Chief Operating Officer & CLO & other: Secretary Paul D. Burgess , and 10 percent owner Shire Human Genetic Therapies, Inc. .
Translate Bio Inc (TBIO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Translate Bio Inc (TBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Translate Bio Inc (TBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Translate Bio Inc (TBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Translate Bio Inc Insider Transactions
Gallagher Brian M. Jr. Mailing Address
Above is the net worth, insider trading, and ownership report for Gallagher Brian M. Jr.. You might contact Gallagher Brian M. Jr. via mailing address: C/o Aileron Therapeutics, Inc., 281 Albany Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
